Published in Ann Neurol on July 01, 1982
Monitoring potential neurotoxic effects of hazardous waste disposal. Environ Health Perspect (1983) 0.87
Effects of vigabatrin on evoked potentials in dogs. Br J Clin Pharmacol (1989) 0.79
Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology (2003) 3.82
Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2003) 3.23
Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol (1975) 2.86
Skin metastases in cancer patients. Cutis (1987) 2.76
Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science (1987) 2.48
Monosodium L-glutamate: its pharmacology and role in the Chinese restaurant syndrome. Science (1969) 2.32
Encephalopathy from abuse of bismuth subsalicylate (Pepto-Bismol) Neurology (1993) 2.27
Ultrastructural studies of the dying-back process. II. The sequestration and removal by Schwann cells and oligodendrocytes of organelles from normal and diseases axons. J Neurocytol (1974) 2.27
Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci U S A (1996) 2.22
Neural correlates of auditory stream segregation in primary auditory cortex of the awake monkey. Hear Res (2001) 1.97
Ultrastructural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication. J Neuropathol Exp Neurol (1974) 1.86
Degeneration in central and peripheral nervous systems produced by pure n-hexane: an experimental study. Brain (1976) 1.84
The sources of auditory evoked responses recorded from the human scalp. Electroencephalogr Clin Neurophysiol (1970) 1.84
Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration. J Neuropathol Exp Neurol (1977) 1.80
Isolation and characterization of glial filaments from human brain. J Cell Biol (1978) 1.74
The examination of isolated nerve fibres by light and electron microscopy, with observations on demyelination proximal to neuromas. Acta Neuropathol (1970) 1.70
Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies. J Neuropathol Exp Neurol (1977) 1.69
Nervous system degeneration produced by the industrial solvent methyl n-butyl ketone. Arch Neurol (1975) 1.66
Antinociceptive activitiy of narcotic agonist and partial agonist analgesics and other agents in the tail-immersion test in mice and rats. Neuropharmacology (1976) 1.61
Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group. Neurology (1999) 1.60
Fatty acid abnormality in adrenoleukodystrophy. J Neurochem (1976) 1.58
Clinical and epidemiologic characteristics of nodding syndrome in Mundri County, southern Sudan. Afr Health Sci (2012) 1.56
Neonatal seizures associated with narcotic withdrawal. J Pediatr (1977) 1.55
The fate of Schwann cells isolated from axonal contact. J Neurocytol (1978) 1.54
Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit Rev Toxicol (2007) 1.54
Striate cortical contribution to the surface-recorded pattern-reversal VEP in the alert monkey. Vision Res (1991) 1.53
Precursors to the development of intention at 6 months: understanding people and their actions. Dev Psychol (2000) 1.51
Environmental antecedents of young-onset Parkinson's disease. Neurology (1993) 1.49
Studies on the control of myelinogenesis. II. Evidence for neuronal regulation of myelin production. Brain Res (1976) 1.49
The acute sensory neuronopathy syndrome: a distinct clinical entity. Ann Neurol (1980) 1.47
Detection of stimulus deviance within primate primary auditory cortex: intracortical mechanisms of mismatch negativity (MMN) generation. Brain Res (1994) 1.46
Sin cib-syn: Accent on glutamate. N Engl J Med (1968) 1.45
An investigation of the auditory streaming effect using event-related brain potentials. Psychophysiology (1999) 1.44
The role of the cranial CT scan in municipal hospitals. Am J Public Health (1980) 1.39
Orienting and habituation to auditory stimuli: a study of short term changes in average evoked responses. Electroencephalogr Clin Neurophysiol (1968) 1.36
The enlarging view of hexacarbon neurotoxicity. Crit Rev Toxicol (1980) 1.36
The reticulum cell sarcoma--microglioma group of brain tumours. A consideration of their clinical features and therapy. Brain (1972) 1.36
Tropism in nerve regeneration in vivo. Attraction of regenerating axons by diffusible factors derived from cells in distal nerve stumps of transected peripheral nerves. Brain Res (1982) 1.36
Nerve compression lesions of the upper extremity. A clinical and experimental review. Clin Orthop Relat Res (1974) 1.35
Taxol produces a predominantly sensory neuropathy. Neurology (1989) 1.32
3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can J Neurol Sci (1991) 1.30
Does a defect of energy metabolism in the nerve fiber underlie axonal degeneration in polyneuropathies? Ann Neurol (1979) 1.29
Consonance and dissonance of musical chords: neural correlates in auditory cortex of monkeys and humans. J Neurophysiol (2001) 1.29
Averaged multiple unit activity as an estimate of phasic changes in local neuronal activity: effects of volume-conducted potentials. J Neurosci Methods (1980) 1.29
A review of acrylamide neurotoxicity. Part II. Experimental animal neurotoxicity and pathologic mechanisms. Can J Neurol Sci (1974) 1.29
2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology (1993) 1.28
Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. II. General pathologic, neuropathologic, and biochemical aspects. Neurology (1977) 1.26
Cognitive and neurologic development of the premature, small for gestational age infant through age 6: comparison by birth weight and gestational age. Pediatrics (1996) 1.26
Effects of centrally acting drugs on exploratory behaviour in rats. Br J Pharmacol Chemother (1965) 1.26
Peripheral neuropathy after occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Am J Ind Med (1993) 1.24
Environmental hydrocarbons produce degeneration in cat hypothalamus and optic tract. Science (1978) 1.24
Nigro-spino-dentatal degeneration with nuclear ophthalmoplegia. A unique and partially treatable clinico-pathological entity. J Neurol Sci (1972) 1.23
Toxic neuropathies. Neurology (1979) 1.22
Human T-lymphotropic virus type I antibodies in the serum of patients with tropical spastic paraparesis in the Seychelles. Arch Neurol (1987) 1.22
Antinociceptive activity of morphine after injection of biogenic amines in the cerebral ventricles of the conscious rat. Br J Pharmacol (1971) 1.21
Strategies to assess validity of self-reported exposures during the Persian Gulf War. Portland Environmental Hazards Research Center. Environ Res (1999) 1.21
Experimental neuropathy produced by 2,5-hexanedione--a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone. J Neurol Neurosurg Psychiatry (1975) 1.21
Neural generators of early cortical somatosensory evoked potentials in the awake monkey. Electroencephalogr Clin Neurophysiol (1995) 1.20
Attention affects the organization of auditory input associated with the mismatch negativity system. Brain Res (1998) 1.20
Click train encoding in primary auditory cortex of the awake monkey: evidence for two mechanisms subserving pitch perception. J Acoust Soc Am (1998) 1.19
Impairment of early cortical processing in schizophrenia: an event-related potential confirmation study. Biol Psychiatry (1993) 1.19
Demonstration of mismatch negativity in the monkey. Electroencephalogr Clin Neurophysiol (1992) 1.18
Neurotoxic fragrance produces ceroid and myelin disease. Science (1979) 1.17
Tonotopic organization of responses reflecting stop consonant place of articulation in primary auditory cortex (A1) of the monkey. Brain Res (1995) 1.17
Studies on the control of myelinogenesis. I. Myelination of regenerating axons after entry into a foreign unmyelinated nerve. J Neurocytol (1975) 1.16
Invited review: peripheral neuropathy in Sjogren's syndrome. Muscle Nerve (1990) 1.15
Pitch vs. spectral encoding of harmonic complex tones in primary auditory cortex of the awake monkey. Brain Res (1998) 1.15
A review of acrylamide neurotoxicity. Part I. Properties, uses and human exposure. Can J Neurol Sci (1974) 1.15
Effect of some amphetamine analogues on -methyl-p-tyrosine-induced catalepsy in rats. Br J Pharmacol (1971) 1.14
Peripheral nerve abnormalities in aging rats. J Neuropathol Exp Neurol (1981) 1.14
Recognizing neurotoxic disease. Neurology (1987) 1.14
Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res (1994) 1.14
Lathyrism: evidence for role of the neuroexcitatory aminoacid BOAA. Lancet (1986) 1.14
Localization of ERP generators and identification of underlying neural processes. Electroencephalogr Clin Neurophysiol Suppl (1995) 1.14
Cellular generators of the cortical auditory evoked potential initial component. Electroencephalogr Clin Neurophysiol (1992) 1.12
Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex. Ann Intern Med (1993) 1.11
CSF-1 deficiency in mice results in abnormal brain development. Development (1996) 1.11
Neurotoxicity of halogenated hydroxyquinolines: clinical analysis of cases reported outside Japan. J Neurol Neurosurg Psychiatry (1979) 1.11
Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol (1992) 1.11